| Typicality: | 0.355 |
| Saliency: | 0.247 |
| between the investigational medication | 11 | other |
| between daily oral administration of lanabecestat | 7 | other |
| in the late 1970s | 2 | temporal |
| trial → evaluate → the relationship | 11 |
| trial → investigate → the relationship | 3 |
| negative | neutral | positive |
| 0.061 | 0.877 | 0.062 |
| Raw frequency | 14 |
| Normalized frequency | 0.247 |
| Modifier score | 0.500 |
| Perplexity | 283.498 |